Competitive Technologies, Inc.’ Calmare(R) Pain Therapy Medical Device Receives Korean FDA Authorization

FAIRFIELD, Conn., July 11, 2011 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that the Korea Food & Drug Administration (KFDA) has authorized sales of the Calmare® medical device featuring “Scrambler Therapy™" in the Republic of Korea. CTTC’s partner, GEOMC Co., Ltd. of Seoul, Korea, which manufactures the Calmare device, will now begin distributing the device in South Korea, in accordance with its agreement with CTTC.

MORE ON THIS TOPIC